The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in ...

For one ICU physician and startup CMO, the more immediate danger isn’t an autonomous system taking over medicine and leaving ...

Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, ...

The FDA is recruiting to fill vacancies on its advisory committees, informally known as adcomms. While these committees have ...

AstraZeneca’s equity investment in Summit Therapeutics comes with plans for clinical trial collaborations. The deal brings ...

Mirum Pharmaceuticals’ Atebrioz is the third FDA-approved drug for fibrodysplasia ossificans progressiva (FOP), but it brings ...

When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...

CertifyOS launched a shared credentialing program that allows providers to submit their information once for multiple health ...

They see the problem first, build the fix, and decide whether it is ever adopted. The market has trained them to hide the one credential that de-risks the deal.

Tiny Health's Series B round was led by B Capital, with participation from Spero Ventures, The Venture City, Overwater Ventures, Black Opal Ventures, Denver Ventures, Pave Health Ventures, Alumni ...

The question is whether these AI tools will be another fragmented layer of technology or true assistants to help them spend ...

The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...